: "Chinese-Brazilian cooperation in science and health reaches a new level"
The two countries are going to sign an agreement that creates the Sino-Brazilian Center for Research and Prevention of Infectious Diseases. The announcement of the unprecedented agreement is scheduled for this Thursday, in Beijing.
This is an initiative of Fiocruz and the CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), through the Institute of Microbiology of the Chinese Academy of Sciences. The Oswaldo Cruz Foundation (Fiocruz) is the most prominent Institution of Science and Technology in Health in Latin America, based in Brazil.
The center will also develop rapid diagnostic tests, therapies, vaccines and drugs.
Among the diseases that will be studied, some affect both countries, such as Covid-19. Others, such as yellow fever, affect Brazil more, but have attracted Chinese interest.
Brazil and China share the vision of healthcare as public goods, such as vaccines, medicines and diagnostic tests.
The two countries are going to sign an agreement that creates the Sino-Brazilian Center for Research and Prevention of Infectious Diseases. The announcement of the unprecedented agreement is scheduled for this Thursday, in Beijing.
This is an initiative of Fiocruz and the CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), through the Institute of Microbiology of the Chinese Academy of Sciences. The Oswaldo Cruz Foundation (Fiocruz) is the most prominent Institution of Science and Technology in Health in Latin America, based in Brazil.
"The center, which will have headquarters in Beijing and another at Fiocruz's Manguinhos Campus, in Rio de Janeiro, will work to strengthen cooperation in the area of science and technology related to health, with a focus on the prevention and control of pandemics and epidemics, such as such as covid-19, influenza , chikungunya, zika, dengue, yellow fever, oropouche and other infectious diseases such as tuberculosis".
The center will also develop rapid diagnostic tests, therapies, vaccines and drugs.
Among the diseases that will be studied, some affect both countries, such as Covid-19. Others, such as yellow fever, affect Brazil more, but have attracted Chinese interest.
"With the increase in Chinese infrastructure works in Africa, some of its workers have contracted yellow fever - a disease for which Fiocruz has know-how, as it produces the vaccine".
"Joint research into infectious diseases in Chinese and Brazilian laboratories, the permanent exchange of experiences and knowledge and the even greater qualification of epidemiological surveillance benefit from the strengthening of our science and enable countries to prepare for new health emergencies, which are increasingly common."
Brazil and China share the vision of healthcare as public goods, such as vaccines, medicines and diagnostic tests.
"The development and production of these goods needs to be decentralized."